Planning Therapy for High-Risk HER2-Positive Early-Stage Breast Cancer: Expert Viewpoint

Download All
Optimize your treatment of patients with high-risk HER2+ EBC with this commentary from our expert, and then download the slides for use in your own practice.
Lee Schwartzberg, MD, FACP

Module

Lee Schwartzberg, MD, FACP, provides his expert opinion on planning therapy for patients with high-risk HER2+ EBC.

Lee Schwartzberg, MD, FACP Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: May 12, 2021 Expired: May 11, 2022

Downloadable slides by Lee Schwartzberg, MD, FACP on planning therapy for patients with high-risk HER2+ Early Breast Cancer

Lee Schwartzberg, MD, FACP Released: May 12, 2021
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
Puma Biotechnology, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue